Data availability
Data will be available upon reasonable request.
References
Huh, J.Y., Panagiotou, G., Mougios, V., Brinkoetter, M., Vamvini, M.T., Schneider, B.E., Mantzoros, C.S. (2012). FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism: clinical and experimental 61(12), 1725–1738. https://doi.org/10.1016/j.metabol.2012.09.002
Colaianni, G., Cinti, S., Colucci, S., Grano, M. (2017). Irisin and musculoskeletal health. Annals of the New York Academy of Sciences 1402(1), 5–9. https://doi.org/10.1111/nyas.13345
Anastasilakis, A.D., Polyzos, S.A., Makras, P., Douni, E., Mantzoros, C.S. (2019). Irisin: good or bad for the bone? A new path forward after the reported discovery of irisin receptor? Metabolism: clinical and experimental 93, 100–102. https://doi.org/10.1016/j.metabol.2019.01.013
Colaianni, G., Faienza, M.F., Sanesi, L., Brunetti, G., Pignataro, P., Lippo, L. et al. (2019). Irisin serum levels are positively correlated with bone mineral status in a population of healthy children. Pediatric Research 85(4), 484–488. https://doi.org/10.1038/s41390-019-0278-y
Colaianni, G., Notarnicola, A., Sanesi, L., Brunetti, G., Lippo, L., Celi, M., Moretti, L., Pesce, V., Vicenti, G., Moretti, B., Colucci, S., Grano, M. (2017). Irisin levels correlate with bone mineral density in soccer players. Journal of Biological Regulators and Homeostatic Agents 31(4 suppl 1), 21–28
Colaianni, G., Errede, M., Sanesi, L., Notarnicola, A., Celi, M., Zerlotin, R. et al. (2021). Irisin correlates positively with BMD in a cohort of older adult patients and downregulates the senescent marker p21 in osteoblasts. Journal of Bone and Mineral Research 36(2), 305–314. https://doi.org/10.1002/jbmr.4192
Anastasilakis, A.D., Polyzos, S.A., Makras, P., Gkiomisi, A., Bisbinas, I., Katsarou, A. et al. (2014). Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months. Osteoporosis International 25(5), 1633–1642. https://doi.org/10.1007/s00198-014-2673-x
Palermo, A., Strollo, R., Maddaloni, E., Tuccinardi, D., D’Onofrio, L., Briganti, S.I. et al. (2015). Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity. Clinical Endocrinology 82(4), 615–619. https://doi.org/10.1111/cen.12672
Yan, J., Liu, H.J., Guo, W.C., Yang, J. (2018). Low serum concentrations of Irisin are associated with increased risk of hip fracture in Chinese older women. Joint Bone Spine 85(3), 353–358. https://doi.org/10.1016/j.jbspin.2017.03.011
Serbest, S., Tiftikci, U., Tosun, H.B., Kisa, U. (2017). The Irisin hormone profile and expression in human bone tissue in the bone healing process in patients. Medical Science Monitor 23, 4278–4283. https://doi.org/10.12659/msm.906293
Polyzos, S.A., Mantzoros, C.S. (2015). An update on the validity of irisin assays and the link between irisin and hepatic metabolism. Metabolism: clinical and experimental 64(9), 937–942. https://doi.org/10.1016/j.metabol.2015.06.005
Zhong, X., Sun, X., Shan, M., Zhao, X., Zhang, R., Zhao, Y., Yang, Q. (2021). The production, detection, and origin of irisin and its effect on bone cells. International Journal of Biological Macromolecules 178, 316–324. https://doi.org/10.1016/j.ijbiomac.2021.02.181
Author contributions
Conception and design of the work: A.D.A., S.A.P. and M.S. Acquisition, analysis, or interpretation of data: A.D.A., S.A.P., K.D., P.M., M.P.Y., A.P., S.G., C.N., I.B. and M.S. Drafting the work: A.D.A. Revising the work critically for important intellectual content: S.A.P., P.M., M.P.Y., A.P. and M.S. Final approval of the submitted version: A.D.A., S.A.P., K.D., P.M., M.P.Y., A.P., S.G., C.N., I.B. and M.S. Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved: A.D.A., S.A.P., K.D., P.M., M.P.Y., A.P., S.G., C.N., I.B. and M.S.
Funding
This work was not supported by any grant, fund, or institution.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in the study were in accordance with the ethical standards of the institutional research committees and with the 1964 Helsinki declaration and its later amendments.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Anastasilakis, A.D., Polyzos, S.A., Kitridis, D. et al. Ιrisin levels in postmenopausal women with an incident hip fracture. Endocrine 73, 719–722 (2021). https://doi.org/10.1007/s12020-021-02738-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-021-02738-6